Per Meg Tirell, in CNN Health “Ozempic shown to reduce drinking in first trial in alcohol-use disorder”.
“For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just curb their desire to eat; for some, they also lead them to drink less alcohol.
Now, the first clinical trial – although relatively small and limited in duration – has confirmed it.
A study of 48 people with signs of moderate alcohol-use disorder found that those taking low doses of semaglutide – the generic name of Ozempic – for nine weeks saw significantly greater reductions in how much alcohol they drank, as well as cravings for alcohol, compared with people on a placebo. The results were published Wednesday in the journal JAMA Psychiatry."
The study was a relatively small study with 48 participants. While the results are promising, larger clinical trials are needed before we can draw any conclustions.